Table 3.
Management of COVID-19 patients in the clinic [38]
| The period from admission to discharge | All patients (N = 1337) |
|---|---|
| Definitions of severe patients | |
| Respiratory rate > 35/min | 212 (15.85%) |
| Mean oxygen saturation < 93% | 195 (14.58%) |
| PaO2/FiO2 ≤ 300 mmHg | 89 (6.65%) |
| Lung lesion progression > 50% within 24–48 h | 26 (1.94%) |
| Treatment | |
| Antiviral therapy | 276 (20.64%) |
| Antibiotic therapy | 266 (19.89%) |
| Use of corticosteroid | 109 (8.15%) |
| Oxygen support | |
| Nasal catheter | 186 (13.91%) |
| Mask oxygen | 89 (6.65%) |
| High-flow nasal cannula | 116 (8.67%) |
| Assisting ventilation | |
| Bipap | 49 (3.66%) |
| Invasive mechanical ventilation | 15 (1.12%) |
| Outcome | |
| Discharge | 188 (14.06%) |
| Continue to be hospitalized | 38 (2.84%) |
| ICU | 19 (1.42%) |
| Death | 29 (2.16%) |